Skip to main content
Erschienen in: Clinical Rheumatology 2/2016

01.02.2016 | Letter to the Editor

Importance of serum amyloid-A in Behçet’s disease

verfasst von: Mehmet Agilli, Fevzi Nuri Aydin, Yasemin Gulcan Kurt, Tuncer Cayci

Erschienen in: Clinical Rheumatology | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Excerpt

Dear Editor, …
Literatur
1.
Zurück zum Zitat Vitale A, Rigante D, Lopalco G, Brizi MG, Caso F, Franceschini R et al (2014) Serum amyloid-A in Behcet’s disease. Clin Rheumatol 33:1165–1167CrossRefPubMed Vitale A, Rigante D, Lopalco G, Brizi MG, Caso F, Franceschini R et al (2014) Serum amyloid-A in Behcet’s disease. Clin Rheumatol 33:1165–1167CrossRefPubMed
2.
Zurück zum Zitat van der Hilst JC (2011) Recent insights into the pathogenesis of type AA amyloidosis. Scientific World Journal 11:641–650CrossRefPubMed van der Hilst JC (2011) Recent insights into the pathogenesis of type AA amyloidosis. Scientific World Journal 11:641–650CrossRefPubMed
3.
Zurück zum Zitat Obici L, Raimondi S, Lavatelli F, Bellotti V, Merlini G (2009) Susceptibility to AA amyloidosis in rheumatic diseases: a critical overview. Arthritis Rheum 61:1435–1440CrossRefPubMed Obici L, Raimondi S, Lavatelli F, Bellotti V, Merlini G (2009) Susceptibility to AA amyloidosis in rheumatic diseases: a critical overview. Arthritis Rheum 61:1435–1440CrossRefPubMed
4.
Zurück zum Zitat Li G, Ren F, Yao J, Wang M, Feng X, Liu D (2013) Human serum amyloid A (SAA) protein changes in acute epilepsy patients. Int J Neurosci 123:265–268CrossRefPubMed Li G, Ren F, Yao J, Wang M, Feng X, Liu D (2013) Human serum amyloid A (SAA) protein changes in acute epilepsy patients. Int J Neurosci 123:265–268CrossRefPubMed
5.
Zurück zum Zitat Fushimi T, Takahashi Y, Kashima Y, Fukushima K, Ishii W, Kaneko K et al (2005) Severe protein losing enteropathy with intractable diarrhea due to systemic AA amyloidosis, successfully treated with corticosteroid and octreotide. Amyloid 12:48–53CrossRefPubMed Fushimi T, Takahashi Y, Kashima Y, Fukushima K, Ishii W, Kaneko K et al (2005) Severe protein losing enteropathy with intractable diarrhea due to systemic AA amyloidosis, successfully treated with corticosteroid and octreotide. Amyloid 12:48–53CrossRefPubMed
6.
Zurück zum Zitat Horiuchi Y, Hirayama S, Soda S, Seino U, Kon M, Ueno T et al (2010) Statin therapy reduces inflammatory markers in hypercholesterolemic patients with high baseline levels. J Atheroscler Thromb 17:722–729CrossRefPubMed Horiuchi Y, Hirayama S, Soda S, Seino U, Kon M, Ueno T et al (2010) Statin therapy reduces inflammatory markers in hypercholesterolemic patients with high baseline levels. J Atheroscler Thromb 17:722–729CrossRefPubMed
7.
Zurück zum Zitat Giugliano D, Ceriello A, Esposito K (2006) The effects of diet on inflammation: emphasis on the metabolic syndrome. J Am Coll Cardiol 48:677–685CrossRefPubMed Giugliano D, Ceriello A, Esposito K (2006) The effects of diet on inflammation: emphasis on the metabolic syndrome. J Am Coll Cardiol 48:677–685CrossRefPubMed
8.
Zurück zum Zitat Spreafico A, Millucci L, Ghezzi L, Geminiani M, Braconi D, Amato L et al (2013) Antioxidants inhibit SAA formation and pro-inflammatory cytokine release in a human cell model of alkaptonuria. Rheumatology (Oxford) 52:1667–1673CrossRef Spreafico A, Millucci L, Ghezzi L, Geminiani M, Braconi D, Amato L et al (2013) Antioxidants inhibit SAA formation and pro-inflammatory cytokine release in a human cell model of alkaptonuria. Rheumatology (Oxford) 52:1667–1673CrossRef
9.
Zurück zum Zitat Pruett BS, Pruett SB (2006) An explanation for the paradoxical induction and suppression of an acute phase response by ethanol. Alcohol 39:105–110PubMedCentralCrossRefPubMed Pruett BS, Pruett SB (2006) An explanation for the paradoxical induction and suppression of an acute phase response by ethanol. Alcohol 39:105–110PubMedCentralCrossRefPubMed
10.
Zurück zum Zitat Al-Sieni AI, Al-Alawy AI, Al-Shehri ZS, Al-Abbasi FA (2013) Serum amyloid-A protein and serum rheumatoid factor as serological surrogate markers for smoking risk factor in Saudi population. Pak J Pharm Sci 26:239–243PubMed Al-Sieni AI, Al-Alawy AI, Al-Shehri ZS, Al-Abbasi FA (2013) Serum amyloid-A protein and serum rheumatoid factor as serological surrogate markers for smoking risk factor in Saudi population. Pak J Pharm Sci 26:239–243PubMed
Metadaten
Titel
Importance of serum amyloid-A in Behçet’s disease
verfasst von
Mehmet Agilli
Fevzi Nuri Aydin
Yasemin Gulcan Kurt
Tuncer Cayci
Publikationsdatum
01.02.2016
Verlag
Springer London
Erschienen in
Clinical Rheumatology / Ausgabe 2/2016
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-014-2860-3

Weitere Artikel der Ausgabe 2/2016

Clinical Rheumatology 2/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.